View in EDS PDF Full Text

Switch to Ritonavir-Boosted versus Unboosted Atazanavir plus Raltegravir Dual-Drug Therapy Leads to Similar Efficacy and Safety Outcomes in Clinical Practice.

Saved in:
Bibliographic Details
Title: Switch to Ritonavir-Boosted versus Unboosted Atazanavir plus Raltegravir Dual-Drug Therapy Leads to Similar Efficacy and Safety Outcomes in Clinical Practice.
Authors: Gantner, Pierre1 pierre.gantner@chru-strasbourg.fr, Bani-Sadr, Firouze2, Garraffo, Rodolphe3, Roger, Pierre-Marie4, Treger, Michèle5, Jovelin, Thomas6, Pugliese, Pascal4, Rey, David1
Source: PLoS ONE. 10/31/2016, Vol. 11 Issue 10, p1-13. 13p.
Database: Academic Search Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 126786677
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Switch to Ritonavir-Boosted versus Unboosted Atazanavir plus Raltegravir Dual-Drug Therapy Leads to Similar Efficacy and Safety Outcomes in Clinical Practice.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Gantner%2C+Pierre%22">Gantner, Pierre</searchLink><relatesTo>1</relatesTo><i> pierre.gantner@chru-strasbourg.fr</i><br /><searchLink fieldCode="AR" term="%22Bani-Sadr%2C+Firouze%22">Bani-Sadr, Firouze</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22Garraffo%2C+Rodolphe%22">Garraffo, Rodolphe</searchLink><relatesTo>3</relatesTo><br /><searchLink fieldCode="AR" term="%22Roger%2C+Pierre-Marie%22">Roger, Pierre-Marie</searchLink><relatesTo>4</relatesTo><br /><searchLink fieldCode="AR" term="%22Treger%2C+Michèle%22">Treger, Michèle</searchLink><relatesTo>5</relatesTo><br /><searchLink fieldCode="AR" term="%22Jovelin%2C+Thomas%22">Jovelin, Thomas</searchLink><relatesTo>6</relatesTo><br /><searchLink fieldCode="AR" term="%22Pugliese%2C+Pascal%22">Pugliese, Pascal</searchLink><relatesTo>4</relatesTo><br /><searchLink fieldCode="AR" term="%22Rey%2C+David%22">Rey, David</searchLink><relatesTo>1</relatesTo>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22PLoS+ONE%22">PLoS ONE</searchLink>. 10/31/2016, Vol. 11 Issue 10, p1-13. 13p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=126786677
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1371/journal.pone.0164240
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 13
        StartPage: 1
    Titles:
      – TitleFull: Switch to Ritonavir-Boosted versus Unboosted Atazanavir plus Raltegravir Dual-Drug Therapy Leads to Similar Efficacy and Safety Outcomes in Clinical Practice.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Gantner, Pierre
      – PersonEntity:
          Name:
            NameFull: Bani-Sadr, Firouze
      – PersonEntity:
          Name:
            NameFull: Garraffo, Rodolphe
      – PersonEntity:
          Name:
            NameFull: Roger, Pierre-Marie
      – PersonEntity:
          Name:
            NameFull: Treger, Michèle
      – PersonEntity:
          Name:
            NameFull: Jovelin, Thomas
      – PersonEntity:
          Name:
            NameFull: Pugliese, Pascal
      – PersonEntity:
          Name:
            NameFull: Rey, David
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 31
              M: 10
              Text: 10/31/2016
              Type: published
              Y: 2016
          Identifiers:
            – Type: issn-print
              Value: 19326203
          Numbering:
            – Type: volume
              Value: 11
            – Type: issue
              Value: 10
          Titles:
            – TitleFull: PLoS ONE
              Type: main
ResultId 1